Status:
COMPLETED
Granulocyte Transfusion Study
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Blood Transfusion
Infection
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
To evaluate granulocyte transfusion therapy with respect to its prophylactic and therapeutic effectiveness to prevent and aid recovery from infection. The study trials were conducted simultaneously.
Detailed Description
BACKGROUND: Infection remains a major cause of death in patients receiving chemotherapy for malignant diseases. One approach to the problem of septicemia and high mortality in these patients was the ...
Eligibility Criteria
Prophylactic Trial: males and females, 12 years or older, who were in the first induction phase of chemotherapy for acute leukemia, who had severe neutropenia, and who did not have documented infection.
Therapeutic Trial: males and females, any
Key Trial Info
Start Date :
September 1 1976
Trial Type :
INTERVENTIONAL
End Date :
September 1 1981
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000581
Start Date
September 1 1976
End Date
September 1 1981
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.